Form 4 for FLGT Fulgent Genetics, Inc.
Accepted 2023-02-27 00:00:00 ET · period of report 2023-02-23 · accession 0001209191-23-013286 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-27 | 2023-02-23 | FLGT | Hsieh Ming | CEO, Dir, 10% | F - Tax | $31.65 | -2,625 | 648.6K | -0.4% | -$83.1K | |
| M | 2023-02-27 | 2023-02-23 | FLGT | Hsieh Ming | CEO, Dir, 10% | A - Grant | $0.00 | +55.0K | 651.2K | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-23 | F | D | 2,625 | $31.65 | 648,555 | D | — | — | (F3) The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022. |
| 2 | Common | Common Stock | 2023-02-23 | A | A | 7,616 | $0.00 | 603,787 | D | — | — | (F1) Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on August 1, 2022. |
| 3 | Common | Common Stock | 2023-02-23 | A | A | 47,393 | $0.00 | 651,180 | D | — | — | (F2) Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after February 23, 2023, and 1/12th of such shares vesting at the end of every three month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date. |